Alerts will be sent to your verified email
Verify Email
SUNPHARMA
|
Sun Pharma Inds.
|
Cipla
|
Torrent Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.67 % | 13.9 % | 20.79 % |
|
5yr Avg Net Profit Margin
|
15.4 % | 14.31 % | 13.95 % |
|
Price to Book
|
5.19 | 4.11 | 15.97 |
|
P/E
|
36.16 | 23.78 | 60.55 |
|
5yr Avg Cash Conversion Cycle
|
-46.88 Days | -4.31 Days | -186.79 Days |
|
5yr Average Interest Coverage Ratio
|
44.12 | 53.73 | 7.38 |
|
5yr Avg ROCE
|
18.0 % | 19.36 % | 25.78 % |
|
5yr Avg Operating Profit Margin
|
26.44 % | 23.02 % | 30.49 % |
|
5 yr average Debt to Equity
|
0.06 | 0.03 | 0.66 |
|
5yr CAGR Net Profit
|
30.35 % | 17.0 % | 8.83 % |
|
5yr Average Return on Assets
|
8.92 % | 11.19 % | 9.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.48 % | 29.19 % | 68.31 % |
|
Share Pledged by Promoters
|
0.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -4.42 % | -2.94 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.79 % | 7.05 % | -2.83 % |
|
Sun Pharma Inds.
|
Cipla
|
Torrent Pharma
|
|---|